StockMarketWire.com - Private healthcare group Mediclinic International said its first-half revenue and operating profits fell, amid a weaker-than-expected performance in the Middle East and Switzerland.

Adjusted Ebitda for the six months through September fell around 8% to around £21.0m, as revenue fell 1% to £1.40bn.

On a constant currency basis, revenue rose 2% but adjusted Ebitda fell around 4%.

In the Middle East, Mediclinic said it delivered a gradual improvement in revenue and margin expansion, ahead of anticipated stronger seasonal growth in the second half of the year.

However, revenue growth for the full year in the Middle East was expected to be lower than expected.

In Switzerland, the business continued to adapt to recent regulatory changes in the outpatient environment, which had a greater than expected impact on admissions.

'In Switzerland, we now expect to deliver modest revenue growth in the full year ... with an adjusted Ebitda margin of around 16%,' chief executive Ronnie van der Merwe said.

In Southern Africa, margins were maintained on lower volumes due to weakness in the second quarter from fewer pneumonia and bronchitis-related cases during the winter.








Story provided by StockMarketWire.com